| 2026-10-15 | Hochstufung | Mizuho | Neutral → Outperform |
| 2026-09-29 | Resumed | Jefferies | Buy |
| 2026-09-18 | Herabstufung | UBS | Buy → Neutral |
| 2026-09-09 | Eingeleitet | Piper Sandler | Neutral |
| 2026-02-26 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2026-02-25 | Hochstufung | BNP Paribas Exane | Neutral → Outperform |
| 2026-01-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2026-01-09 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-11-10 | Hochstufung | Seaport Research Partners | Neutral → Buy |
| 2025-11-06 | Bestätigt | TD Cowen | Hold |
| 2025-10-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-09-30 | Eingeleitet | Deutsche Bank | Buy |
| 2025-09-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-03-17 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-03-07 | Hochstufung | Guggenheim | Neutral → Buy |
| 2025-02-28 | Herabstufung | Seaport Research Partners | Buy → Neutral |
| 2025-02-28 | Bestätigt | TD Cowen | Hold |
| 2025-02-06 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2025-01-10 | Herabstufung | Susquehanna | Positive → Neutral |
| 2024-11-08 | Bestätigt | TD Cowen | Hold |
| 2024-11-07 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-11-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-09-04 | Resumed | Jefferies | Buy |
| 2024-08-09 | Herabstufung | ROTH MKM | Buy → Neutral |
| 2024-08-09 | Bestätigt | TD Cowen | Hold |
| 2024-07-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-28 | Eingeleitet | Susquehanna | Positive |
| 2024-05-10 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-02 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-03-22 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2024-03-05 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-02-28 | Herabstufung | Exane BNP Paribas | Neutral → Underperform |
| 2024-02-28 | Bestätigt | TD Cowen | Market Perform |
| 2024-01-22 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-12-19 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-15 | Eingeleitet | Jefferies | Hold |
| 2023-11-21 | Eingeleitet | Mizuho | Neutral |
| 2023-10-20 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2023-10-17 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-28 | Eingeleitet | Janney | Buy |
| 2023-05-18 | Eingeleitet | Seaport Research Partners | Buy |
| 2023-04-11 | Eingeleitet | Wolfe Research | Outperform |
| 2023-04-03 | Resumed | Morgan Stanley | Underweight |
| 2023-03-28 | Hochstufung | Truist | Hold → Buy |
| 2023-03-10 | Eingeleitet | Citigroup | Neutral |
| 2023-03-02 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-12-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-12-06 | Eingeleitet | Wells Fargo | Overweight |
| 2022-09-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-08-05 | Eingeleitet | Barclays | Overweight |
| 2022-06-06 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2022-05-23 | Eingeleitet | Northland Capital | Outperform |
| 2022-05-11 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2022-05-02 | Resumed | Truist | Hold |
| 2022-04-06 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-01-24 | Bestätigt | Truist | Hold |
| 2022-01-18 | Resumed | Guggenheim | Neutral |
| 2021-12-14 | Eingeleitet | Colliers Securities | Buy |
| 2021-10-20 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-10-15 | Eingeleitet | Truist | Hold |
| 2021-08-12 | Resumed | Guggenheim | Buy |
| 2021-08-10 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2021-07-20 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-07-14 | Resumed | Credit Suisse | Outperform |
| 2021-05-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-05-12 | Herabstufung | Barclays | Overweight → Underweight |
| 2021-05-12 | Bestätigt | Cowen | Market Perform |
| 2021-05-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-05-12 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2021-04-22 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-04-16 | Hochstufung | UBS | Neutral → Buy |
| 2021-03-29 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2021-03-10 | Hochstufung | Johnson Rice | Accumulate → Buy |
| 2021-01-20 | Eingeleitet | Johnson Rice | Accumulate |
| 2021-01-08 | Eingeleitet | Piper Sandler | Overweight |
| 2020-12-09 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-09 | Eingeleitet | ROTH Capital | Buy |
| 2020-11-09 | Eingeleitet | Barclays | Equal Weight |
| 2020-11-09 | Eingeleitet | Cowen | Market Perform |
| 2020-11-09 | Eingeleitet | Credit Suisse | Neutral |
| 2020-11-09 | Eingeleitet | Goldman | Buy |
| 2020-11-09 | Eingeleitet | Guggenheim | Buy |
| 2020-11-09 | Eingeleitet | JP Morgan | Neutral |
| 2020-11-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2020-11-09 | Eingeleitet | Oppenheimer | Perform |
| 2020-11-09 | Eingeleitet | UBS | Neutral |